Finance

Beta
Lists
4598:TYO
Delta-Fly Pharma Inc
¥148.00
+2.07%
(+3.00) 1D
Jun 2, 2:13:03 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4598...
Open
¥144
High
¥150
Low
¥142
Mkt. cap
2.09B
Avg. vol.
366.62K
Volume
306.00K
52-wk high
¥793
52-wk low
¥142
EPS
-¥140
Shares outstanding
4.37M
No. of employees
13
Open
¥144
High
¥150
Low
¥142
Mkt. cap
2.09B
Avg. vol.
366.62K
Volume
306.00K
52-wk high
¥793
52-wk low
¥142
EPS
-¥140
Shares outstanding
4.37M
No. of employees
13
News stories
From sources across the web
About Delta-Fly Pharma Inc
CEO-
Employees13
FoundedDec 6, 2010
Headquarters-
SectorBiotechnology
Websitedelta-flypharma.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
284.00M
413.00M
335.00M
297.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
74.00M
60.00M
68.00M
74.00M
Operating expense
358.00M
473.00M
403.00M
371.00M
Total operating expenses
358.00M
473.00M
403.00M
371.00M
Operating income
-358.00M
-473.00M
-403.00M
-371.00M
Other non operating income
-10.00M
1.00M
-4.00M
-5.00M
EBT including unusual items
-367.00M
-473.00M
-407.00M
-376.00M
EBT excluding unusual items
-367.00M
-473.00M
-407.00M
-376.00M
Income tax expense
-
1.00M
-
1.00M
Effective tax rate
-
-0.21%
-
-0.27%
Other operating expenses
-
-
-
-
Net income
-367.00M
-474.00M
-407.00M
-377.00M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-357.75M
-472.75M
-402.75M
-370.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer